Literature DB >> 22436

Inhibitory activity of terfenadine on histamine-induced skin wheals in man.

K J Hüther, G Renftle, N Barraud, J T Burke, J Koch-Weser.   

Abstract

The inhibitory effect of orally administered terfenadine on the area of histamine-induced skin wheals was studied by single dose and multiple dose trials in 12 normal male volunteers. Single doses of 20, 60 and 200 mg of terfenadine produced dose-dependent decreases in histamine wheal area that reached a maximum by the fourth hour after dosing. The 60 and 200 mg doses blocked almost 90% of histamine whealing, and significant reduction of the wheal area persisted for 8 h. During the multiple dose trial histamine whealing was markedly inhibited after the fifth and sixth dose of terfenadine 20, 40 or 60 mg every 8 h and of 60 mg every 12 h. On the last three dosage schedules inhibition persisted for at least 12 h after the final dose. Inhibition of histamine-induced skin whealing appears to be a quantitative index of the time course of histamine H1-receptor antagonist action.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 22436     DOI: 10.1007/BF00609860

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  8 in total

1.  Inhibition of experimental skin wheal by some ataractic and antihistaminic drugs.

Authors:  E DUNDAS; J H TOOGOOD; J WANKLIN
Journal:  J Allergy       Date:  1961 Jan-Feb

2.  One year's experience with sustained release antihistamine medication; an experimental and clinical study.

Authors:  M A GREEN
Journal:  Ann Allergy       Date:  1954 May-Jun

3.  The quantitative comparison of histamine antagonists in man.

Authors:  W A BAIN
Journal:  Proc R Soc Med       Date:  1949-08

4.  Experiment on healthy volunteers with the new antihistamine 22-914 (Sandoz).

Authors:  A Petrin
Journal:  Int J Clin Pharmacol Biopharm       Date:  1975-07

5.  The evaluation of histamine antagonists in man.

Authors:  A S Fowle; D T Hughes; G J Knight
Journal:  Eur J Clin Pharmacol       Date:  1971-09       Impact factor: 2.953

6.  A new approach to the use of histamine skin tests in the study of antihistamine drugs.

Authors:  L Joubert; Z Gaut; W B Abrams
Journal:  Clin Pharmacol Ther       Date:  1969 Mar-Apr       Impact factor: 6.875

7.  Relationship between antihistamic activity and plasma level of diphenhydramine.

Authors:  W Bilzer; U Gundert-Remy; E Weber
Journal:  Eur J Clin Pharmacol       Date:  1974-08-23       Impact factor: 2.953

8.  A comparison of triprolidine and clemastine on histamine antagonism and performance tests in man: implications for the mechanism of drug induced drowsiness.

Authors:  A W Peck; A S Fowle; C Bye
Journal:  Eur J Clin Pharmacol       Date:  1975-08-14       Impact factor: 2.953

  8 in total
  21 in total

1.  The pharmacokinetics, antihistamine and concentration-effect relationship of ebastine in healthy subjects.

Authors:  J Vincent; R Liminana; P A Meredith; J L Reid
Journal:  Br J Clin Pharmacol       Date:  1988-11       Impact factor: 4.335

2.  Chronopharmacological study of antihistamines in man with special references to terfenadine.

Authors:  A Reinberg; F Levi; P Guillet; J T Burke; A Nicolai
Journal:  Eur J Clin Pharmacol       Date:  1978-12-01       Impact factor: 2.953

Review 3.  Rational use of antihistamines in allergic dermatological conditions.

Authors:  C Advenier; C Queille-Roussel
Journal:  Drugs       Date:  1989-10       Impact factor: 9.546

4.  Mechanism of action of antipruritic drugs.

Authors:  L Krause; S Shuster
Journal:  Br Med J (Clin Res Ed)       Date:  1983-10-22

5.  Comparison of the central and peripheral effects of cetirizine and terfenadine.

Authors:  J C Pechadre; D Vernay; J F Trolese; M Bloom; P Dupont; J P Rihoux
Journal:  Eur J Clin Pharmacol       Date:  1988       Impact factor: 2.953

6.  The effect of topical dimethindene maleate on weal reactions.

Authors:  F Humphreys; S Shuster
Journal:  Br J Clin Pharmacol       Date:  1987-02       Impact factor: 4.335

Review 7.  Terfenadine. The first nonsedating antihistamine.

Authors:  H C Masheter
Journal:  Clin Rev Allergy       Date:  1993

8.  Performance studies with the H1-histamine receptor antagonists, astemizole and terfenadine.

Authors:  A N Nicholson; B M Stone
Journal:  Br J Clin Pharmacol       Date:  1982-02       Impact factor: 4.335

9.  The effects of astemizole on histamine-induced weal and flare.

Authors:  D N Bateman; P H Chapman; M D Rawlins
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

10.  The H1-antagonist mequitazine: studies on performance and visual function.

Authors:  A N Nicholson; B M Stone
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.